Jim Glasheen, PhD, a prominent venture capitalist in the biopharmaceutical, medical technology and patient-centered health fields, will join UMass Medical School on Dec. 4 as the executive vice chancellor for innovation & business development, according to an announcement from Chancellor Michael F. Collins and Dean Terence R. Flotte. Dr. Glasheen will succeed Brendan O’Leary, PhD, a scientist and former venture capitalist who, for more than three years, has led a comprehensive approach to business development, innovation and advancing industry partnerships as the office’s founding executive vice chancellor.

https://www.umassmed.edu/news/news-archives/2017/11/jim-glasheen-named-executive-vice-chancellor-innovation--business-development/